Clinical trial
A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During…
NCT00327392 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00327392 |
|---|---|
| Title | A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. |
| Official title | A Phase 3 Open-Label, Single Arm Study to Assess the Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal-to-Moderate Sedation in Patients Undergoing Minor Surgical Procedures |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Procedural Sedation |
| Intervention type | Drug |
| Interventions | AQUAVAN® (fospropofol disodium) Injection |
| Enrollment | 123 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | May 18, 2006 |
| Last update posted | Jun 20, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: